About Replay
Replay is a company based in San Diego (United States) founded in 2021 by Ron Weiss, David Knipe, and Lachlan MacKinnon was acquired by LEO Pharma in April 2026. It operates as a HealthTech. Replay has raised $55 million across 2 funding rounds from investors including LEO Pharma, KKR and Gates Foundation. The company has 13 employees as of December 31, 2021. Replay offers products and services including Big DNA Delivery. Replay operates in a competitive market with competitors including BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others.
- Headquarter San Diego, United States
- Employees 13 as on 31 Dec, 2021
- Founders Ron Weiss, David Knipe, Lachlan MacKinnon
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Replay Holdings, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$55 M (USD)
in 2 rounds
-
Latest Funding Round
$1.5 M (USD), Grant
Nov 28, 2022
-
Investors
LEO Pharma
& 8 more
-
Employee Count
13
as on Dec 31, 2021
-
Acquired by
LEO Pharma
(Apr 30, 2026)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Replay
Replay offers a comprehensive portfolio of products and services, including Big DNA Delivery. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Big DNA delivery is developed for disease treatment.
Unlock access to complete
Funding Insights of Replay
Replay has successfully raised a total of $55M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $1.5 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $1.5M
-
First Round
First Round
(25 Jul 2022)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2022 | Amount | Grant - Replay | Valuation |
investors |
|
| Jul, 2022 | Amount | Seed - Replay | Valuation | KKR , OMX Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Replay
Replay has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include LEO Pharma, KKR and Gates Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by this private equity firm.
|
Founded Year | Domain | Location | |
|
Venture capital investments are made in transformative biotech companies by OMX Ventures.
|
Founded Year | Domain | Location | |
|
Early-stage startups are invested in by Artis Ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Replay
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Replay
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Replay Comparisons
Competitors of Replay
Replay operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare and ultra-rare metabolic diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Replay
Frequently Asked Questions about Replay
When was Replay founded?
Replay was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Where is Replay located?
Replay is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Replay?
Lachlan MacKinnon is the current CEO of Replay. They have also founded this company.
Is Replay a funded company?
Replay is a funded company, having raised a total of $55M across 2 funding rounds to date. The company's 1st funding round was a Seed of $55M, raised on Jul 25, 2022.
How many employees does Replay have?
As of Dec 31, 2021, the latest employee count at Replay is 13.
What does Replay do?
Replay is engaged in developing big DNA delivery solutions for treating monogenic and polygenic diseases through gene therapy. The company specializes in delivering 150kb DNA using HSV technology. Their efforts are centered in the biotechnology sector, aiming to address complex genetic disorders with innovative therapeutic approaches.
Who are the top competitors of Replay?
Replay's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
What products or services does Replay offer?
Replay offers Big DNA Delivery.
Who are Replay's investors?
Replay has 9 investors. Key investors include LEO Pharma, KKR, Gates Foundation, Salt Mobile, and OMX Ventures.